-
October 19, 2011 Lupin receives FDA approval for Generic KEPPRA® Oral Solution 100 mg / ml
-
October 11, 2011 Lupin launches Authorized Generic of Femcon® Fe
-
September 14, 2011 Lupin Announces Launch of Generic KEPPRA XR® Tablets
-
September 11, 2011 Lupin Announces U.S. FDA Approval of its First Oral Contraceptive
-
September 2, 2011 Sanofi Aventis & Multicare Ink Strategic Agreement in the Philippines
-
August 31, 2011 Lupin Receives Final Approval to Market Generic Ultram® ER
-
July 29, 2011 Eli Lilly India and Lupin announce strategic collaboration to help fight the battle against diabetes
-
July 27, 2011 Consistent Growth, Net Sales up 17% India and Japan Drive Growth
-
July 25, 2011 Lupin and Medicis Enter into Joint Development Agreement
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications